Related Laws Explorer

Emergency stock supply of epinephrine in schools with cost coverage.

Allows entities to be prescribed epinephrine for immediate administration.

Assesses feasibility of in-state manufacturing of insulin, naloxone, albuterol, and epinephrine.

Ensures safe medication administration including epinephrine in emergencies.

Requires stock supply of non-patient specific epinephrine in schools.

Caps the price of epinephrine auto-injectors through insurance regulation.

This pending legislation would require all schools in Massachusetts to maintain a stock supply of non-patient specific epinephrine auto-injectors to be used in the event of an anaphylactic emergency.

School Epinephrine Mandate Bill

A pending 2025 bill that would transition Mississippi from a permissive stock epinephrine state to a mandatory one, requiring every school building and cafeteria to maintain a supply of auto-injectors.

This bill broadens the mechanisms permitted for the emergency administration of epinephrine in schools, institutions of higher education, and youth camps.

Mandatory Stock Epinephrine Bill

This pending legislation would shift the current 'permissive' stock epinephrine policy to a 'mandatory' one, requiring all school districts, boards of cooperative educational services, and charter schools to maintain epinephrine auto-injectors on site.

Rhode Island School Emergency Medication Mandate

Proposed legislation that would transition Rhode Island from a 'permissive' stocking state to a 'required' stocking state for both epinephrine and undesignated asthma rescue inhalers in schools.

HB 333

Proposed legislation to expand the definition of 'epinephrine auto-injector' to 'injectable epinephrine rescue medication,' potentially allowing for lower-cost delivery methods like vials and syringes.

Federal bill to cap the cost of life-saving epinephrine injectors by establishing cost-sharing requirements under group health plans and health insurance coverage.

Requires private health insurers to provide epinephrine products without deductibles, copayments, or coinsurance.

Mandates health insurers cover epinephrine for individuals 18 or younger.

Emergency stock supply of epinephrine in schools with cost coverage.

Caps the price of epinephrine auto-injectors through insurance regulation.

New York Asthma Inhaler Coverage Act (S.3100A)

S.3100A expands New York insurance coverage for the treatment of asthma to include a second rescue and maintenance inhaler, along with any medically necessary devices for children. New Yorkers with asthma can face large financial barriers to drugs that hinder optimal treatment; high out-of-pocket costs hinder adherence, threaten patient health, and exacerbate health disparities. The bill passed the Senate 59-2 on March 17, 2025 and was reported and committed to the Finance Committee on May 12, 2026.